{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:55:41Z","timestamp":1790420141804,"version":"4.1.0"},"reference-count":31,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4465,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1997,2]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Autoimmune haemolytic anaemia (AIHA) is one of the major complications in chronic lymphocytic leukaemia (CLL). Treatment with alkylating agents and the adenosine analogue, fludarabine, might trigger the development of AIHA in CLL patients despite the reduction of leukaemic clone. The influence of 2\u2010chlorodeoxyadenosine (2\u2010CdA) on AIHA in patients with CLL is undefined so far. In a group of 114 patients treated at our clinics with this agent, AIHA with direct antiglobulin test (DAT) positively was observed in 25 (21.9%) patients. In 23 patients AIHA was noticed before the starting of 2\u2010CdA and in 2 patients DAT became positive after 2\u2010CdA treatment. In 6 patients the drug caused complete resolution of haemolysis and DAT became negative. Eight patients exhibited partial resolution of haemolysis with significant improvement in haemoglobin level but DAT test remained positive. In 11 patients there was no response to 2\u2010CdA in relation to autoimmune haemolysis. Two patients with no previous history of haemolysis developed AIHA after 5 and 6 courses of 2\u2010CdA therapy and their DAT became positive 1\u20132 months after the last course of the drug. One of them entered severe haemolytic crisis and severe thrombocytopenia and died because of haemorrhagy to the central nervous system. In the other patient AIHA was controlled by steroids and chlorambucil treatment. Our study indicates that 2\u2010CdA may suppress autoimmunohaemolytic process in some patients with CLL and trigger the development of AIHA in others.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1997.tb00933.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T11:02:24Z","timestamp":1279450944000},"page":"109-113","source":"Crossref","is-referenced-by-count":43,"title":["Autoimmune haemolytic anaemia in patients with chronic lymphocytic eukaemia treated with 2\u2010chlorodeoxyadenosine (cladribine)"],"prefix":"10.1111","volume":"58","author":[{"given":"T.","family":"Robak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"B\u0142asi\u0144ska\u2010Morawiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Krykowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hellmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Konopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"73","volume-title":"The lymphoid leukaemias","author":"Catowsky D.","year":"1990"},{"key":"e_1_2_1_3_2","first-page":"209","article-title":"Biology of chronic lymphocytic leukemia","volume":"4","author":"Gale RP","year":"1987","journal-title":"Semin Hematol"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-7-525"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood.V81.10.2475.2475","article-title":"Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases","volume":"81","author":"Kipps TJ","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830320314"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199109068099"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609051736"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.7.2463.2463"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1182\/blood.V72.3.1069.bloodjournal7231069","article-title":"2\u2010Chloro\u2010deoxydenosine: an effective new agent for the treatment of chronic lymphocytic leukemia","volume":"72","author":"Piro LD","year":"1988","journal-title":"Blood"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.4.679"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609051736"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199309054731"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05300.x"},{"key":"e_1_2_1_15_2","first-page":"768","article-title":"Fludarabine\u2010related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia","volume":"92","author":"Maclean R.","year":"1996","journal-title":"Br J Haematol"},{"key":"e_1_2_1_16_2","first-page":"119","article-title":"2\u2010Chlorodeoxyadenosine treatment of patients with chronic lymphocytic leukaemia associated with autoimmune haemolysis","volume":"25","author":"Zaucha JM","year":"1994","journal-title":"Acta Haematol Pol"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830480423"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V46.2.219.219"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja00333a046"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830290307"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.8.1901.1901"},{"key":"e_1_2_1_22_2","first-page":"1615","article-title":"The chronic leukemias: a review of disease manifestations and the aim of therapy","volume":"96","author":"Bergsagel DE.","year":"1967","journal-title":"Can Med Assoc J"},{"key":"e_1_2_1_23_2","first-page":"147","volume-title":"Chronic lymphocytic leukemia","author":"Foa R.","year":"1993"},{"key":"e_1_2_1_24_2","first-page":"403","article-title":"Incidence and prognostic significance of autoantibodies against erythrocytes and platelets in chronic lymphocytic leukemia (CLL)","volume":"30","author":"Rossi G.","year":"1988","journal-title":"Nouv Rev Fr Hematol"},{"issue":"1","key":"e_1_2_1_25_2","first-page":"282","article-title":"Chronic lymphocytic leukemia: clinical studies based on 189 cases followed for a long time","volume":"18","author":"Hansen MM.","year":"1973","journal-title":"Scand J Haematol"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/08830189109061774"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1182\/blood.V78.6.1503.1503","article-title":"Autoantibody\u2010associated cross\u2010reactive idiotype\u2010bearing human B lymphocytes: distribution and characterization, including IgVH gene and CD5 antigenic expression","volume":"78","author":"Inghirami G.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.169.1.255"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30123-0"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(94)90009-4"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1182\/blood.V78.6.1569.1569","article-title":"Decreased CD45RA T\u2010cells in B\u2010cell chronic lymphocytic leukemia patients: correlation with disease stage","volume":"78","author":"Peller S.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_32_2","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood.V81.12.3484.3484","article-title":"2\u2010Chlorodeoxyadenosine in the treatment of chronic refractory immune thrombocytopenic purpura","author":"Figuerda M.","year":"1993","journal-title":"Blood"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1997.tb00933.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1997.tb00933.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T10:36:06Z","timestamp":1698402966000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1997.tb00933.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,2]]}},"alternative-id":["10.1111\/j.1600-0609.1997.tb00933.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1997.tb00933.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,2]]}}}